母体外显子组分析用于诊断卵母细胞成熟缺陷和早期胚胎发育停滞
研究开发了一套病例筛选与全外显子组测序(WES)分析方法,用于因复发性卵母细胞成熟缺陷(OOMD)和/或植入前胚胎致死(PREMBL)而不孕的女性。基于11221对夫妇的IVF数据建立统计方法识别内表型,对28例患者行WES,发现7例(25%)携带已知候选基因的纯合错义致病变异,并发现ENSA为新关联基因。
要点
- 基于大样本IVF数据可统计识别复发性低卵母细胞成熟率、低受精率及植入前发育停滞等内表型。
- 28例OOMD/PREMBL患者中7例(25%)携带PATL2、NLRP5、TLE6、PADI6、TUBB8或TRIP13的纯合错义致病变异。
- 一例低卵母细胞成熟率患者为ENSA高影响变异纯合携带者,提示新基因-疾病关联。
核心结论
- 该分析框架可揭示与孤立性复发性OOMD/PREMBL相关的已知和新基因,为将该策略扩展至更大规模研究提供必要指征。
研究设计与样本
- 数据收集自2015年至2021年在伊斯坦布尔纪念医院就诊的IVF患者。
- 利用大型IVF数据集(11221对夫妇)开发统计方法识别不孕内表型(复发性低卵母细胞成熟率、低受精率和植入前发育停滞)。
- 随后纳入28例OOMD/PREMBL不孕女性,对其基因组DNA行全外显子组测序(WES)。
- WES和生物信息学分析在Igenomix和意大利国家研究委员会完成。
主要发现
- 变异优先级分析鉴定出248个基因中的265个独特变异(平均每样本22.4个)。
- 携带高影响变异的基因中78%由MII卵母细胞和/或窦卵泡颗粒细胞表达,显著高于对照随机样本(比值比=5,Fisher精确检验P=0.0004)。
- 28例女性中7例(25%)为已知OOMD/PREMBL候选基因(包括PATL2、NLRP5(n=2)、TLE6、PADI6、TUBB8和TRIP13)错义致病变异的纯合携带者。
- 一例低卵母细胞成熟率女性为ENSA高影响变异的纯合携带者,ENSA是小鼠第一次减数分裂前期转变的必需基因。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Can a methodology be developed for case selection and whole-exome sequencing (WES) analysis of women who are infertile owing to recurrent oocyte maturation defects (OOMD) and/or preimplantation embryo lethality (PREMBL)? DESIGN: Data were collected from IVF patients attending the Istanbul Memorial Hospital (2015-2021). A statistical methodology to identify infertile endophenotypes (recurrent low oocyte maturation rate, low fertilization rate and preimplantation developmental arrest) was developed using a large IVF dataset (11,221 couples). Twenty-eight infertile women with OOMD/PREMBL were subsequently enrolled for WES on their genomic DNA. Pathogenic variants were prioritized using a custom-made bioinformatic pipeline set to minimize false-positive discoveries through resampling in control cohorts (the Human Genome Diversity Project and 1343 whole-exome sequences from oocyte donors). Individual single-cell RNA sequencing data from 18 human metaphase II (MII) oocytes and antral granulosa cells was used for genome-wide validation. WES and bioinformatics were performed at Igenomix and the National Research Council, Italy. RESULTS: Variant prioritization analysis identified 265 unique variants in 248 genes (average 22.4 per sample). Of the genes harbouring high-impact variants 78% were expressed by MII oocytes and/or antral granulosa cells, significantly higher than for random sample of controls (odds ratio = 5, Fisher's exact P = 0.0004). Seven of the 28 women (25%) were homozygous carriers of missense pathogenic variants in known candidate genes for OOMD/PREMBL, including PATL2, NLRP5 (n = 2),TLE6, PADI6, TUBB8 and TRIP13. Furthermore, novel gene-disease associations were identified. In fact, one woman with a low oocyte maturation rate was a homozygous carrier of high-impact variants in ENSA, an essential gene for prophase I meiotic transition in mice. CONCLUSIONS: This analytical framework could reveal known and new genes associated with isolated recurrent OOMD/PREMBL, providing essential indications for scaling this strategy to larger studies.
引用
- Capalbo A, Buonaiuto S, Figliuzzi M, et al. Maternal exome analysis for the diagnosis of oocyte maturation defects and early embryonic developmental arrest. Reprod Biomed Online. 2022. PMID: 35798635. doi:10.1016/j.rbmo.2022.05.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。